Le Lézard
Classified in: Business
Subject: ATY

TWIST BIOSCIENCE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST


NEW ORLEANS, Jan. 27, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Twist Bioscience Corporation (NasdaqGS: TWST), if they purchased the Company's shares between December 13, 2019 and November 14, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.

Get Help

Twist Bioscience investors should visit us at https://claimsfiler.com/cases/nasdaq-twst/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

Twist Bioscience and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On November 15, 2022, Scorpion Capital reported that the Company is "operating a Ponzi-like scheme that will end in bankruptcy," that the Company's growth and revenues were unsustainable, and that the Company was perpetuating its fraud through false reporting of capital expenditures and gross margins, among other issues. On this news, shares of Twist Bioscience fell $7.57 per share, or nearly 20%, from a close of $38.00 per share on November 14, 2022, to close at $30.43 per share on November 15, 2022.

The case is Peters v. Twist Bioscience Corporation, et al., No. 22-cv-08168.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

SOURCE ClaimsFiler


These press releases may also interest you

at 02:35
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic...

at 02:30
Kredivo Holdings (formerly known as FinAccel), the parent company of Kredivo and Krom Bank Indonesia, today announced that it has raised ~US$270 million in equity financing in a significantly oversubscribed round, bringing its Series D fundraise to a...

at 02:17
111, Inc. ("111" or the "Company") , a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter...

at 02:16
CAIXA ECONÔMICA FEDERAL ("CAIXA"), the largest Brazilian bank in number of clients, credit, digital accounts and savings deposits, announces its consolidated result for the fourth quarter result (4Q22). HIGHLIGHTS: I.  Accounting Net Income of R$ 2.2...

at 02:05
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results1 for the year ending December 31, 2022. The consolidated financial statements are attached to this press release. "In...

at 02:01
Boeing [NYSE:BA] and Japan Airlines (JAL) have finalized an order for 21 super-efficient 737-8 jets. The versatile 737-8 will...



News published on 27 january 2023 at 22:50 and distributed by: